4,4'-((2-(5-(2-FLUORO-3-METHOXYPHENYL)-3-(2-FLUORO-6-(TRIFLUOROMETHYL)BENZYL)-4-METHYL-2,6-DIOXO-3,6-DIHYDROPYRIMIDIN-1(2H)-YL)-1-PHENYLETHYL)AZANEDIYL)DIBUTYRIC ACID, (R)-
UNII LP8M953L39
Substance Identification & Data
This profile provides standardized clinical and technical data for 4,4'-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2h)-yl)-1-phenylethyl)azanediyl)dibutyric Acid, (r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LP8M953L39.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2409132-60-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C36H36F5N3O7 HWYCCACGKNRWJX-NDEPHWFRSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4,4'-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2h)-yl)-1-phenylethyl)azanediyl)dibutyric Acid, (r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.